These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9488202)

  • 41. Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.
    Hernández-Hernández R; Armas-Padilla MC; Velasco M; Carvajal AR; Armas de Hernández MJ; Guerrero-Pajuelo J; Pacheco B
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):323-31. PubMed ID: 10442506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study).
    Hong TT; Huang J; Driscoll E; Lucchesi BR
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):526-33. PubMed ID: 16160608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty.
    Bates ER; McGillem MJ; Mickelson JK; Pitt B; Mancini GB
    Circulation; 1991 Dec; 84(6):2463-9. PubMed ID: 1659954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of aspirin and metoclopramide produces a synergistic antithrombotic effect in a canine model of coronary artery thrombosis.
    Duval N; Grosset A; O'Connor SE
    Fundam Clin Pharmacol; 1997; 11(1):57-62. PubMed ID: 9182077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis.
    Hennan JK; Swillo RE; Morgan GA; Leik CE; Brooks JM; Shaw GD; Schaub RG; Crandall DL; Vlasuk GP
    Thromb Haemost; 2006 Mar; 95(3):469-75. PubMed ID: 16525575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. II. Adjunctive therapy with r-hirudin.
    Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):203-11. PubMed ID: 7511748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.
    Greenbaum AB; Ohman EM; Gibson CM; Borzak S; Stebbins AL; Lu M; Le May MR; Stankowski JE; Emanuelsson H; Weaver WD
    Am Heart J; 2007 Oct; 154(4):702-9. PubMed ID: 17892995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine.
    Nylander M; Lindahl TL; Bengtsson T; Grenegård M
    Platelets; 2008 Aug; 19(5):352-8. PubMed ID: 18791941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relative effects of aspirin on platelet aggregation and prostaglandin-mediated coronary vasodilatation in the dog.
    Capurro NL; Lipson LC; Bonow RO; Goldstein RE; Shulman NR; Epstein SE
    Circulation; 1980 Dec; 62(6):1221-7. PubMed ID: 7438358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
    Rovin JD; Stamler JS; Loscalzo J; Folts JD
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):626-31. PubMed ID: 7505366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
    Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
    Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts.
    Asanuma H; Minamino T; Sanada S; Ogita H; Kim J; Fujita M; Hirata A; Tsukamoto O; Ogai A; Node K; Hori M; Tomoike H; Kitakaze M
    J Mol Cell Cardiol; 2005 Oct; 39(4):605-14. PubMed ID: 16087189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats.
    Behrend EN; Grauer GF; Greco DS; Rose BJ; Thrall MA
    J Am Anim Hosp Assoc; 1996; 32(1):11-8. PubMed ID: 8963730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.
    Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL
    Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.